Drug Manufacturing & Quality Control

To help ensure the consistency and quality of drug products, Rigaku provides a range of analytical technologies suited to the characterization of multi-component blends and products. Using orthogonal analytical techniques like fluorescence, spectroscopy, and diffraction combined with fundamental parameters quantitative approaches and chemometrics to help monitor blend and content uniformity along with any induced solid form changes. With X-ray CT microscopy, the 3D microstructure of the final dosage form can be used as a benchmark of pharmaceutical equivalence and related to dissolution behavior and therapeutic performance.